[ON-DEMAND] Sponsored Presentation from WCG: Streamlining Biosafety: The Power of Centralized IBC Services
Wednesday, December 6, 2023
7:30 AM – 8:15 AM ET
Sponsored By
This session will be offered on-demand only for in-person SBER23 registrants, and PRIMR23/SBER23 Virtual Meeting registrants; there is no live interaction. A live version of this session will be held on December 5 from 5:15-6:00 PM in the Industry Expert Theater in the Exhibit Hall!
For most clinical trials involving gene transfer products, such as mRNA, CAR-T cells, viral vectors, the research must be approved by an IBC prior to initiation. Although each site needs to have a separate IBC approval, the approval process in multicenter trials can be managed in a centralized manner to enhance efficiency, transparency, and compliance. This presentation will highlight major advantages of working with an expert central IBC service provider.
Learning Objectives:
Be able to explain requirements for IRB of clinical trials involving engineered DNA, RNA, and gene transfer
Outline the requirements and best practices for conducting IBC reviews to ensure safety and compliance
Highlight the advantages and efficiencies of centralized IBC review services for sponsors, CROs, sites, and institutions
